Literature DB >> 22552601

Impact of human granulocyte and monocyte isolation procedures on functional studies.

Lu Zhou1, Rajesh Somasundaram, Rosa F Nederhof, Gerard Dijkstra, Klaas Nico Faber, Maikel P Peppelenbosch, Gwenny M Fuhler.   

Abstract

One of the first lines of defense against infection is the activation of the innate immune system. It is becoming clear that autoimmune diseases, such as rheumatoid arthritis and Crohn's disease, may be caused by disturbed innate immunity, and relating granulocyte and monocyte functions to the patient genotype has become an important part of contemporary research. Although it is essential to move this field forward, a systematic study comparing the efficacy and suitability for functional studies of the various available protocols for the isolation of these immune cells has not been performed. Here, we compare human granulocyte functionality under three enrichment protocols: (i) Ficoll density gradient centrifugation, (ii) anti-CD15 antibody-conjugated microbeads (positive selection), and (iii) Polymorphoprep. Primary monocytes were isolated in parallel using (i) anti-CD14 magnetic microbeads, (ii) non-monocyte depletion by antibody-conjugated magnetic microbeads (negative selection), (iii) RosetteSep antibody cocktail, and (iv) the classical adherence protocol. The best results in terms of purity and cell functionality were obtained with positive selection by magnetic microbeads for both human granulocytes and monocytes. Whereas phagocytosis of Escherichia coli bacteria was identical in all isolation procedures tested, the granulocyte respiratory burst was higher in positively selected cells. In addition, different granulocyte enrichment procedures affect cell surface receptor expression to different extents. In toto, we propose that positive selection of granulocytes and monocytes be adopted as the procedure of choice for studies of human granulocyte and monocyte functions but caution investigators to be aware of possible alterations in cell phenotypes with different isolation procedures.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22552601      PMCID: PMC3393372          DOI: 10.1128/CVI.05715-11

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  30 in total

1.  Innate immunity in the etiopathology of autoimmunity.

Authors:  M Carroll
Journal:  Nat Immunol       Date:  2001-12       Impact factor: 25.606

2.  Synovial fluid neutrophils transcribe and express class II major histocompatibility complex molecules in rheumatoid arthritis.

Authors:  Andrew Cross; Roger C Bucknall; Marco A Cassatella; Steven W Edwards; Robert J Moots
Journal:  Arthritis Rheum       Date:  2003-10

Review 3.  Neutrophils in the pathogenesis and manifestations of SLE.

Authors:  Mariana J Kaplan
Journal:  Nat Rev Rheumatol       Date:  2011-09-27       Impact factor: 20.543

Review 4.  Monocyte and macrophage abnormalities in systemic lupus erythematosus.

Authors:  Yi Li; Pui Y Lee; Westley H Reeves
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2010-07-31       Impact factor: 4.291

5.  Leukocyte function in chronic granulomatous disease of childhood. Studies on a seventeen year old boy.

Authors:  G L Mandell; E W Hook
Journal:  Am J Med       Date:  1969-09       Impact factor: 4.965

6.  Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis.

Authors:  B T Wipke; P M Allen
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

7.  Induction of a novel mechanism of accelerated bacterial clearance by lipopolysaccharide in CD14-deficient and Toll-like receptor 4-deficient mice.

Authors:  A Haziot; N Hijiya; S C Gangloff; J Silver; S M Goyert
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

8.  Polymorphonuclear neutrophils as accessory cells for T-cell activation: major histocompatibility complex class II restricted antigen-dependent induction of T-cell proliferation.

Authors:  M Radsak; C Iking-Konert; S Stegmaier; K Andrassy; G M Hänsch
Journal:  Immunology       Date:  2000-12       Impact factor: 7.397

9.  Quantification of uncultured Ruminococcus obeum-like bacteria in human fecal samples by fluorescent in situ hybridization and flow cytometry using 16S rRNA-targeted probes.

Authors:  Erwin G Zoetendal; Kaouther Ben-Amor; Hermie J M Harmsen; Frits Schut; Antoon D L Akkermans; Willem M de Vos
Journal:  Appl Environ Microbiol       Date:  2002-09       Impact factor: 4.792

10.  Reduced expression of flavocytochrome b558, a component of the NADPH oxidase complex, in neutrophils from patients with myelodysplasia.

Authors:  Gwenny M Fuhler; Floris Hooijenga; A Lyndsay Drayer; Edo Vellenga
Journal:  Exp Hematol       Date:  2003-09       Impact factor: 3.084

View more
  38 in total

1.  Concurrent isolation of lymphocytes and granulocytes using prefocused free flow acoustophoresis.

Authors:  Carl Grenvall; Cecilia Magnusson; Hans Lilja; Thomas Laurell
Journal:  Anal Chem       Date:  2015-05-13       Impact factor: 6.986

2.  Erythrocyte sialoglycoproteins engage Siglec-9 on neutrophils to suppress activation.

Authors:  Anel Lizcano; Ismael Secundino; Simon Döhrmann; Ross Corriden; Cristina Rohena; Sandra Diaz; Pradipta Ghosh; Lingquan Deng; Victor Nizet; Ajit Varki
Journal:  Blood       Date:  2017-04-17       Impact factor: 22.113

3.  The effect of cell subset isolation method on gene expression in leukocytes.

Authors:  Nadejda Beliakova-Bethell; Marta Massanella; Cory White; Steven Lada; Pinyi Du; Florin Vaida; Julià Blanco; Celsa A Spina; Christopher H Woelk
Journal:  Cytometry A       Date:  2013-09-20       Impact factor: 4.355

4.  Sourcing of an alternative pericyte-like cell type from peripheral blood in clinically relevant numbers for therapeutic angiogenic applications.

Authors:  Anna Blocki; Yingting Wang; Maria Koch; Anna Goralczyk; Sebastian Beyer; Nikita Agarwal; Michelle Lee; Shehzahdi Moonshi; Jean-Yves Dewavrin; Priscilla Peh; Herbert Schwarz; Kishore Bhakoo; Michael Raghunath
Journal:  Mol Ther       Date:  2014-12-12       Impact factor: 11.454

5.  Generation of Immature, Mature and Tolerogenic Dendritic Cells with Differing Metabolic Phenotypes.

Authors:  Wen Jing Sim; Frano Malinarich; Anna-Marie Fairhurst; John Edward Connolly
Journal:  J Vis Exp       Date:  2016-06-22       Impact factor: 1.355

6.  Identification of Iguratimod as an Inhibitor of Macrophage Migration Inhibitory Factor (MIF) with Steroid-sparing Potential.

Authors:  Joshua Bloom; Christine Metz; Saisha Nalawade; Julian Casabar; Kai Fan Cheng; Mingzhu He; Barbara Sherry; Thomas Coleman; Thomas Forsthuber; Yousef Al-Abed
Journal:  J Biol Chem       Date:  2016-10-28       Impact factor: 5.157

7.  Monocyte isolation techniques significantly impact the phenotype of both isolated monocytes and derived macrophages in vitro.

Authors:  Marlene C Nielsen; Morten N Andersen; Holger J Møller
Journal:  Immunology       Date:  2019-11-27       Impact factor: 7.397

8.  Macrophage migration inhibitory factor enhances Pseudomonas aeruginosa biofilm formation, potentially contributing to cystic fibrosis pathogenesis.

Authors:  Aisling Tynan; Leona Mawhinney; Michelle E Armstrong; Ciaran O'Reilly; Sarah Kennedy; Emma Caraher; Karen Jülicher; David O'Dwyer; Lewena Maher; Kirsten Schaffer; Aurélie Fabre; Edward F McKone; Lin Leng; Richard Bucala; Jürgen Bernhagen; Gordon Cooke; Seamas C Donnelly
Journal:  FASEB J       Date:  2017-08-02       Impact factor: 5.191

9.  Snapshot Profiling of the Antileishmanial Potency of Lead Compounds and Drug Candidates against Intracellular Leishmania donovani Amastigotes, with a Focus on Human-Derived Host Cells.

Authors:  Markela Koniordou; Stephen Patterson; Susan Wyllie; Karin Seifert
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

10.  Effect of Antiretroviral Therapy on HIV-mediated Impairment of the Neutrophil Antimycobacterial Response.

Authors:  David M Lowe; Nonzwakazi Bangani; Rene Goliath; Beate Kampmann; Katalin A Wilkinson; Robert J Wilkinson; Adrian R Martineau
Journal:  Ann Am Thorac Soc       Date:  2015-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.